Related by context. All words. (Click for frequent words.) 77 Anti PlGF 74 anti PlGF 67 Shigatoxin producing E. coli 67 NS5b 67 hypersensitivity reactions eg anaphylaxis 66 pneumocystis pneumonia PCP 66 RhuDex TM 65 oropharyngeal candidiasis OPC 65 oral nucleoside analogue 65 essential thrombocythemia ET 65 Amgen Neulasta R 65 Drug Candidate 65 MKC# MT 65 Lenocta TM 65 non nucleoside inhibitor 65 patients coinfected 64 Amgen Neulasta ® 64 Videx Videx EC 64 orally administered inhibitor 64 Phase 2b Clinical Trial 64 COPEGUS R 64 itraconazole Sporanox 64 dasatinib Sprycel ® 63 Mg Uk 63 Initiates Phase II 63 HCV NS5B polymerase 63 treatment naïve genotype 63 Budesonide foam crofelemer 63 Personalized Immunotherapy 63 Naive Patients 63 Thiovir 63 Atripla combines 63 Mg Usa 63 Peginterferon alfa 2b 63 selective immunoproteasome inhibitor 62 Albuferon TM 62 AAG geldanamycin analog 62 nasal decolonization 62 Tezampanel 62 novel emulsion formulation 62 lexidronam injection 62 HCV polymerase 62 LymphoStat B belimumab 62 e antigen HBeAg 62 Intravitreal injections 62 XL# anticancer compounds 62 Associated Diarrhea 62 CYT# potent vascular disrupting 62 telaprevir VX 62 myelodysplastic myeloproliferative diseases 62 Vitrasert R 62 Late Breaker 62 relapsed MM 62 Initiates Clinical Trial 62 alfa 2a 62 trastuzumab Herceptin R 62 PEGylated Fab fragment 62 virus HCV protease inhibitor 62 RhuDex ® 62 Achieves Primary Endpoint 61 RhuDex R 61 toenail onychomycosis 61 IAP inhibitor 61 phase III isavuconazole 61 receptor tyrosine kinase inhibitor 61 refractory chronic lymphocytic 61 Begins Dosing 61 2 methoxyestradiol 61 Valopicitabine 61 polycythemia vera essential thrombocythemia 61 Adjuvanted 61 cSSSIs 61 ALN HPN 61 Pafuramidine 61 Receives Orphan Drug Designation 61 myoglobinuria rhabdomyolysis 61 RELOVAIR ™ 61 HCV Hepatitis C 61 Polymerase Inhibitor 61 investigational oral hepatitis C 61 Entry Inhibitor 61 vaginal candidiasis 61 tuberculosis hepatitis B 61 TKB# 61 ergot derivatives 61 nucleoside analog 61 PNP inhibitor 61 pan histone deacetylase 61 elevated creatine phosphokinase 61 NS5B polymerase 61 vapreotide acetate 61 Pharmacokinetics PK 61 MAGE A3 ASCI 61 Patients Treated With 61 GVAX ® 61 rifabutin 61 fluconazole resistant 61 Sustiva efavirenz 61 sorafenib tablets 61 VP# [004] 61 ADP receptor antagonist 61 Protease Inhibitor 61 Clavulanate 60 Peginterferon Alfa 2a 60 Vicriviroc 60 oral proteasome inhibitor 60 Investigational Oral 60 Daclizumab 60 indinavir Crixivan 60 pyrazinamide 60 Hsp# Inhibitor 60 DEB# 60 Preclinical Data 60 brivanib 60 Parkinson disease levodopa induced 60 Xeloda ® 60 methylnaltrexone bromide 60 hepatitis C HCV 60 beta 1a 60 topical gel formulation 60 miconazole Lauriad ® 60 Dose Ranging Study 60 oral prodrug 60 PROSTASCINT R 60 compound INCB# 60 Pegloticase 60 KSP inhibitor 60 VISICOL R 60 Initiates Enrollment 60 Rigel R# 60 Submits NDA 60 COLAZAL R 60 GATTEX ™ 60 novel oral tubulin 60 Phase 1b clinical trials 60 chills fever headache 60 IMiDs ® 60 FDA APPROVES 59 PEGylated anti 59 Pruvel TM 59 Adenoviral 59 PRN FDA Approves 59 CCR5 antagonist 59 CYP#A# CYP#D# 59 SinuNase ™ 59 Demonstrates Efficacy 59 Bavituximab 59 ara C 59 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 59 Hepatitis C Viral 59 5 HT3 antagonist 59 CCR5 receptor antagonist 59 Announces Tentative Approval 59 nosocomial pneumonia 59 NEUGENE 59 nasal carriage 59 Humanized Anti 59 Previously Treated 59 octreotide acetate 59 Initiate Phase 59 Varicella zoster virus 59 fibrosis IPF 59 hypereosinophilic syndrome 59 Sapacitabine 59 virus HCV 59 Files IND 59 AEG# 59 administered concomitantly 59 HMG CoA reductase inhibitors 59 brand ciclesonide HFA 59 penicillin amoxicillin 59 Emtriva Viread 59 Presents Preclinical Data 59 HIV treatments Reyataz 59 Epivir R 59 reverse transcriptase inhibitors 59 included exfoliative dermatitis 59 conserved antigens NP 59 acyclovir Zovirax 59 treatment naive genotype 59 nilotinib Tasigna ® 59 zidovudine AZT 59 XL# XL# XL# XL# 59 infection sinusitis 59 Bilive R combined 59 Peginterferon 59 valacyclovir Valtrex 59 TRIOLEX HE# APOPTONE HE# 59 erlotinib Tarceva ® 59 Nitazoxanide 59 Shows Efficacy 59 FACTIVE ® 59 Anidulafungin 59 Nebulized 59 nucleoside reverse transcriptase inhibitor 59 CD4 monoclonal antibody 59 AKT inhibitor 59 Kinase Inhibitor 59 Antiviral Activity 59 cisplatin gemcitabine 59 Interferon Beta 59 Bacille Calmette Guérin BCG 59 BioNeutral antimicrobial formulations 58 gets USFDA nod 58 HGS ETR1 mapatumumab 58 non resectable metastatic 58 Refractory Hodgkin Lymphoma 58 HyperAcute 58 FOLFOX6 58 radezolid 58 5 fluorouracil leucovorin 58 K. pneumoniae 58 Epothilone D 58 SPRYCEL ® 58 Bordetella pertussis 58 Viread tenofovir disoproxil fumarate 58 Diarrheal 58 HIV coinfected 58 FUSILEV enhances 58 CTAP# Capsules 58 TO AVOID PREGNANCY WHILE 58 HCV polymerase inhibitors 58 RTP #i 58 lead Aganocide compound 58 Silodosin 58 Resistant Staphylococcus Aureus 58 Eltrombopag 58 HBeAg + 58 GW# [003] 58 im peramivir 58 docetaxel Taxotere ® 58 Clevudine 58 humanized therapeutic 58 acyclovir Lauriad R 58 potent triglyceride lowering 58 saquinavir ritonavir 58 Telik logo TELINTRA 58 alpha folate receptor 58 polymerase inhibitor 58 OMP #M# 58 capreomycin 58 Aflibercept 58 TMC# [002] 58 NASH Huntington 58 dexamethasone Decadron 58 hypoxia activated prodrug 58 Pharmos pipeline 58 Cethromycin 58 MORAb 58 Tigecycline 58 Soft Tissue Sarcoma 58 Enterococcus faecium 58 MOVIPREP R 58 virus HBV 58 IN PATIENTS WITH 58 tenofovir Viread 58 genotypic resistance 58 Macrolide 58 Phase #b/#a clinical 58 Hydrochlorothiazide Tablets 58 R Saizen R 58 Edurant 58 Lubiprostone 58 thalidomide Thalomid 58 Second Pivotal Phase 58 Histoplasmosis 58 TM Aganocide 58 TYGACIL 58 Initiate Clinical Trial 58 Copegus ® 58 non nucleoside 58 Antiviral Therapy 58 tazobactam 58 sores onychomycosis nail 58 chickenpox varicella 58 cytomegalovirus immune globulin 58 sulfamethoxazole 58 Monoclonal 58 Recombinant Human 58 potassium binder 58 ® lenalidomide 57 diarrhea fatigue asthenia 57 aldehyde dehydrogenase ALDH2 deficiency 57 anticancer antiviral 57 K ras mutations 57 sunitinib Sutent ® 57 treat chronic sinusitis 57 oral FTY# 57 Complicated Skin 57 Beclomethasone 57 tumor xenograft models 57 investigational integrase inhibitor 57 Haemophilus b Conjugate 57 Phase Ib clinical trials 57 Augment ™ 57 selective phosphodiesterase 57 Progressive Multifocal Leukoencephalopathy 57 Reports Preclinical Data 57 oral chemotherapeutic agent 57 intravesical infusion therapy 57 MVA HPV IL2 57 ELND-#/AZD-# 57 peripherally restricted 57 complicated intra abdominal 57 ciprofloxacin Cipro 57 broad spectrum cephalosporin 57 Deforolimus 57 dornase alfa 57 Integrase Inhibitor 57 1mg 2mg 57 fluoroquinolone class 57 Mycophenolate Mofetil 57 Darinaparsin 57 INVANZ 57 TLR9 agonist 57 PANVAC VF 57 Copegus R 57 Files Investigational 57 PrevOnco 57 angioneurotic edema 57 Intercell investigational 57 FDA Clears 57 cromolyn sodium 57 anti botulism antibody 57 humanised monoclonal antibody 57 Pseudomonas lung 57 HCV RNA polymerase 57 Piperacillin 57 pegylated interferon alfa 2a 57 DG# compounds targeting 57 triciribine phosphate monohydrate 57 imatinib Gleevec ® 57 Orally Active 57 generation antisense inhibitor 57 ritonavir boosted 57 Inactivated 57 Moxifloxacin 57 BARACLUDE ® 57 adenosine A2A 57 intranasal formulation 57 antisense inhibitors 57 Immune Globulin Human 57 DermaVir Patch 57 lamivudine zidovudine 57 Initiates Phase 2b 57 SYN# 57 PDX pralatrexate 57 FDA Accepts 57 MT# MEDI 57 lumefantrine 57 EPIVIR 57 unique alkylating agent 57 Monopril 57 VEGFR2 inhibitor 57 mitoxantrone plus 57 FOLFOX6 chemotherapy regimen 57 attach auristatin 57 Vancomycin resistant 57 Radezolid 57 abacavir lamivudine 57 tigecycline 57 investigational antibiotic 57 nucleotide analog 57 oral picoplatin 57 nonnucleoside reverse transcriptase inhibitors 57 CYT# vascular disrupting 57 alpha 2a 57 Ketorolac 57 vinca alkaloid 57 immune globulin intravenous 57 Obatoclax 57 TBC# 57 iobenguane 57 Kinesin Spindle Protein KSP 57 oral ridaforolimus 57 HCV protease inhibitor 57 selective modulator 57 MetroGel 57 mertansine 57 Rifampicin 57 Parathyroid Hormone 57 Presents Preclinical 57 Submits IND 57 STEC O# 57 oral beclomethasone dipropionate 57 Enterobacter cloacae 57 Soriatane R 56 Cloretazine ® 56 nonnucleoside reverse transcriptase inhibitor 56 TNF Tumor Necrosis Factor 56 metastatic colorectal carcinoma 56 REGN# 56 MDS AML 56 MEK inhibitor 56 Clindamycin 56 Carbapenems 56 cells uL 56 Septin9 biomarker 56 elvucitabine 56 developing Zerenex ferric 56 drug resistant Streptococcus 56 secretory phospholipase A2 56 Phase Ib II 56 nonbacterial 56 recurrent NSCLC 56 cyclin dependent kinase CDK 56 Aurora kinase inhibitor 56 Folfox 56 Indibulin ZIO 56 anaphylaxis dyspnea flushing 56 WX UK1 56 myeloproliferative neoplasms MPNs 56 Plaquenil 56 Delafloxacin 56 Camptosar ® 56 targeted radiotherapeutic 56 Boceprevir 56 tumors GIST 56 metastatic androgen independent 56 PI3K/Akt pathway inhibitor 56 Candida infection 56 Proquin XR 56 Anthracyclines 56 targeted nucleotide prodrug 56 intravenous belinostat 56 tenofovir disoproxil fumarate Viread 56 Racivir 56 Severe hypersensitivity reactions 56 PEGASYS ® 56 molecular imaging radiopharmaceutical 56 nucleotide analogue 56 Transdermal Patch 56 3TC lamivudine Epivir 56 VQD 56 Zemiva TM 56 ABLYNX 56 Cloretazine 56 metastatic pancreatic 56 mg RDEA# 56 NRTI resistance 56 Shows Statistically Significant 56 cefazolin 56 investigational hepatitis C 56 FDA Approvals 56 Alfacell proprietary ribonuclease 56 Muraglitazar 56 induces antibodies 56 nausea vomiting rash 56 Initiates Clinical 56 COPEGUS ribavirin 56 Xyfid TM 56 rifamycin 56 HCV Genotype 56 Trimethoprim 56 ALVESCO ® 56 Akt inhibitor 56 elevated creatinine phosphokinase 56 recurrent metastatic 56 metformin XR 56 Klebsiella pneumonia 56 IND Application 56 Flavivirus 56 COMBIVIR 56 Onalta TM 56 IMiDs R 56 lenalidomide Revlimid R 56 Haemophilus 56 Ecallantide 56 proprietary radiolabeled monoclonal 56 Sanofi Pasteur ALVAC canary 56 generation Hsp# inhibitor 56 Telatinib 56 ChronVac C R 56 Levoleucovorin 56 Pyridorin TM 56 Plavix clopidogrel bisulfate 56 generation oxazolidinone 56 endothelin receptor antagonists 56 histone deacetylase HDAC inhibitor 56 ß blockers 56 Phase Ib study 56 CYT# QbG# 56 HCV replicon 56 Voreloxin 56 alvespimycin 56 5 FU leucovorin 56 gemifloxacin mesylate tablets fluoroquinolone 56 COLAZAL ® 56 ENMD # 56 Streptococcus pyogenes 56 Emtriva emtricitabine 56 ® bortezomib 56 assessing T DM1 56 Vidaza ® 56 Bacteremia 56 rabeprazole 56 TLR7 agonist 56 Prodrug 56 Vaxfectin formulated 56 glycopeptide 56 recurrent metastatic ovarian cancer 56 orally dosed 56 Irinotecan 56 IMiD 56 Seliciclib 56 ceftazidime 56 SUVN 56 beta lactam antibiotic 56 abacavir sulfate lamivudine 56 enoxaparin Lovenox 56 specific CCR9 antagonist 56 Maribavir 56 administered intranasally 56 investigational protease inhibitor 56 APTIVUS 56 SPL# Gel vaginal microbicide 56 NeutroPhase TM 56 Bazedoxifene 56 nucleoside naive 56 Anticancer Compound 56 rheumatoid arthritis osteoarthritis ankylosing 55 acute peripheral arterial 55 EGFR HER2 55 PSMA ADC 55 monoclonal antibody MAb 55 Staphylococcal 55 CTAP# Injection 55 cefixime 55 chronic HCV genotype 55 Immunomodulatory 55 Super EPO erythropoietin 55 multicenter Phase III 55 Respiratory Virus 55 idiopathic thrombocytopenic purpura ITP 55 Bosutinib 55 AZT zidovudine Retrovir 55 norfloxacin 55 sublingual tablet formulation 55 Copegus ribavirin 55 Posaconazole 55 pan HDAC inhibitor 55 irinotecan doxorubicin oxaliplatin paclitaxel 55 SMZ TMP 55 Elvitegravir 55 topical ophthalmic 55 accumulate preferentially 55 non constipating irritable 55 IMPDH inhibitor 55 protein tyrosine phosphatase 1B 55 semi synthetic lipoglycopeptide 55 Tipranavir 55 Panzem R NCD 55 Bayer HealthCare Onyx Pharmaceuticals 55 cetuximab Erbitux R 55 Factor VIIa 55 Bezielle 55 triggers apoptosis programmed 55 polymerase inhibitors 55 Antifungal 55 volociximab 55 Orally administered 55 XL# XL# 55 Fludara ® 55 hypocalcaemia 55 potently inhibit 55 coagulation disorders 55 Intravitreal 55 peginterferon alpha 2a 55 CHEAP ONLINE PHARMACY LOW 55 Genotyping Test 55 bevirimat Study 55 SCH # 55 dimer protein 55 Phase IIa trials 55 hydrochlorothiazide HCTZ 55 aripiprazole Abilify 55 Nephrol 55 metastatic castrate resistant 55 histone deacetylase inhibitor 55 OncoVex 55 huN# DM1 55 Phase Ib clinical 55 meropenem 55 Roflumilast 55 ORENCIA ® 55 refractory NSCLC 55 vesicular monoamine transporter 55 MVA BN R 55 DOXIL R 55 amantadine Symmetrel 55 NS#/#A protease 55 Escherichia coli Klebsiella pneumoniae 55 AAG KOS 55 EQUIP OB 55 Inhalation Powder 55 echinocandin 55 combines bupropion 55 Cancidas 55 Tesmilifene 55 carbapenem resistant 55 Therapeutic Competitors Report 55 selective antagonist 55 Abstract Number 55 antibody MAb 55 gemcitabine Gemzar ® 55 Traficet EN 55 tetracycline antibiotic 55 metastatic malignant 55 Multimeric 55 investigational HCV polymerase 55 gastrin analogue TT 55 Stimulon adjuvant 55 oral rivaroxaban 55 docetaxel Taxotere R 55 Rifampin 55 acting neuraminidase inhibitor 55 zonisamide SR 55 BiTE ® 55 Romidepsin 55 abacavir Ziagen 55 pneumocystis carinii pneumonia 55 Capecitabine 55 Eraxis 55 DepoCyt 55 methicillin sensitive 55 generation purine nucleoside 55 benazepril 55 Phase Ib IIa 55 Disease Modifying 55 HCl Injection 55 Pancreas Cancer Vaccine 55 HCV SPRINT 55 oral candidiasis 55 Triapine R 55 inhibitor RG# 55 Guanilib 55 Protease 55 UPLYSO 55 CCR5 tropic 55 boosted protease inhibitor 55 Oncolytic 55 long acting muscarinic 55 Cytarabine 55 ALTROPANE R 55 Bafetinib 55 cytomegalovirus retinitis 55 non nucleoside HCV 55 virus HBV infection 55 PegIFN 55 CEQ# 55 evaluating tivozanib 55 Rimantadine 55 Medoxomil 55 BENICAR HCT 54 mg TID 54 anionic backbone 54 efavirenz emtricitabine 54 liposomal amphotericin B 54 Pruvel 54 estramustine 54 #-# Full Text 54 penicillin resistant Streptococcus 54 Isavuconazole 54 mapatumumab 54 PRTX 54 transcriptase inhibitor NNRTI 54 oral antifungal 54 ethinyl estradiol tablets 54 Ganciclovir 54 lamotrigine Lamictal 54 topical ocular 54 Therapeutic Competitors Companies 54 SAR# [002] 54 occlusion PAO 54 Fluticasone 54 Angiotensin Converting Enzyme 54 Retisert R 54 Vitro Activity 54 galiximab 54 Fluconazole 54 efavirenz Sustiva 54 vinorelbine tartrate 54 confirmatory Phase IIIb 54 nucleotide analog polymerase inhibitor 54 systemically administered 54 investigational immunotherapy 54 Darunavir 54 regorafenib 54 receiving VELCADE 54 lumiliximab 54 worming heartworm test 54 mg eq 54 JAK#/JAK# inhibitor CYT# 54 paclitaxel Taxol ® 54 Omacetaxine 54 Imetelstat 54 interferon alfa 2a 54 ug dose 54 Raltegravir 54 Oral corticosteroids 54 gemcitabine carboplatin 54 Celgosivir 54 Interferon alfa 54 Twinrix 54 ULTRASE 54 peginterferon alfa 54 Xatral R 54 Belerofon 54 Telithromycin 54 statin monotherapy 54 virologically suppressed 54 administered subcutaneously 54 beta lactamase inhibitor 54 chemotherapy cisplatin 54 sunitinib malate 54 infliximab monotherapy 54 PegIFN RBV 54 Aptivus ® 54 neuraminidase inhibitor 54 dasatinib Sprycel 54 proteasome inhibitor 54 balsalazide disodium Capsules 54 5 HT6 receptor 54 CIMZIA TM 54 Epivir 54 pneumoniae PRSP 54 muscarinic receptor agonist 54 Ceftaroline 54 plus prednisone prednisolone 54 Staccato alprazolam 54 Receives Approvable Letter 54 novel topoisomerase 54 Pradefovir 54 Hepatitis C virus HCV 54 nucleoside polymerase inhibitor 54 Naproxen sodium 54 YONDELIS 54 microtubule inhibitor 54 novel defensin mimetic 54 RG# ITMN 54 Bortezomib 54 Topical Gel 54 emtricitabine Emtriva 54 Aclidinium 54 M2 subunit 54 Pegylated interferon 54 Linezolid 54 adalimumab Humira 54 elotuzumab 54 REP# 54 Gets FDA Clearance 54 INVEGA ® 54 protease inhibitor PI 54 ciprofloxacin hydrochloride 54 Vidofludimus 54 bortezomib Velcade R 54 generation nucleoside analog 54 Multaq dronedarone 54 ertapenem 54 atovaquone 54 atazanavir Reyataz 54 Methicillin resistant S. aureus 54 nucleoside analogues 54 intra arterial chemotherapy 54 virus BVDV 54 Ofloxacin 54 small molecule tyrosine 54 Intravenous Human 54 JVRS 54 penicillin G benzathine 54 telaprevir dosed 54 gemcitabine cisplatin 54 containing abacavir 54 lung pancreatic 54 topical antifungal 54 demonstrated antitumor activity 54 metformin sulfonylurea 54 liposome injection 54 MAGE A3 protein 54 Papillomavirus 54 Bacillus Calmette Guerin 54 non resectable 54 orally inhaled 54 Adjunctive 54 RGB # 54 bevacizumab Avastin R 54 PTK# 54 genotype 1b 54 rNAPc2 54 dihydrochloride 54 sitagliptin metformin 54 Rheumatoid Arthritis Drug 54 capecitabine Xeloda 54 sodium glucose cotransporter 54 novel nucleoside analog 54 Intradermal 54 NXL# 54 EOquin TM phase 54 Corynebacterium 54 Streptococcus pneumonia 54 Vidaza azacitidine 54 TRISENOX ® 54 selective A2A adenosine receptor 54 Toxoid 54 oral Hsp# inhibitor 54 calcineurin inhibitors 54 Virulizin ® 54 Septin 9 biomarker 54 Fluorouracil 54 nasally administered 54 Jay Knopka 54 small molecule Hedgehog 54 davunetide intranasal AL 53 docetaxel Taxotere 53 pyrimethamine 53 Alocrest 53 R abatacept 53 TREATMENT OF 53 clinical trials Archexin 53 arteritis 53 R#/MEM # 53 Tetanus Toxoid Reduced Diphtheria 53 PPAR gamma agonist 53 piperacillin tazobactam 53 Nexavar ® 53 MET amplification 53 methicillin susceptible Staphylococcus aureus 53 inhalation powder 53 emtricitabine FTC 53 ribavirin RBV 53 fumarate 53 Rotavirus Vaccines 53 DOXIL 53 anti secretory 53 cytarabine daunorubicin 53 Xelox 53 blinded randomized placebo controlled 53 lopinavir ritonavir Kaletra 53 TO TREAT 53 bactericidal activity 53 CLL SLL 53 PSN# [002] 53 KM HR.WITH HIGHER GUSTS 53 mg/m2 administered 53 etanercept Enbrel 53 penicillins cephalosporins 53 CTA# Injection 53 alpha 2b 53 oral dihydropyrimidine dehydrogenase DPD 53 IgM antibody 53 amprenavir 53 lipoglycopeptide 53 CLINICAL STUDIES 53 Drug resistant strains 53 Cytotoxic 53 systemic RNAi therapeutic 53 Panzem NCD 53 NOX E# 53 compound perifosine 53 Margo Quatrino 53 abstr 53 Oral Suspension USP 53 fever cough headache 53 adriamycin 53 ritonavir boosted protease inhibitor 53 beta lactams 53 AZASAN R 53 PRICE GREAT DISCOUNT FREE 53 Retisert ® 53 quinolone 53 Aztreonam lysine 53 Alferon N 53 MYCAMINE 53 peripherally acting 53 highly selective inhibitor 53 world safest multivalent 53 Interferon beta 1a 53 inverse agonist 53 Dalbavancin 53 tenofovir disoproxil fumarate 53 macrolide antibiotic 53 procainamide 53 Staphylococcus epidermidis 53 periocular infections 53 immunotherapeutic vaccine 53 VELCADE melphalan 53 Diffuse Large B 53 injectable investigational 53 erythematosus 53 pegylated alpha interferon 53 polyglutamate 53 Xanafide 53 Gastrointestinal Stromal Tumors 53 Fovea Pharmaceuticals subsidiary 53 sorafenib Nexavar 53 Replacement Therapy 53 5mg #mg 53 cephalosporin antibiotics 53 Forodesine 53 liposomal formulation 53 benzimidazole 53 Rhinocort 53 Jim Tretola 53 astemizole 53 capsular polysaccharide 53 refractory Hodgkin 53 Gemzar gemcitabine 53 treat atopic dermatitis 53 HQK 53 resistant Staphylococcus aureus MRSA 53 intravesical instillation 53 Aplidin R 53 humanized monoclonal antibody 53 Bendamustine 53 Crofelemer 53 Clinical manifestations 53 Alagebrium 53 COPD inhalation anthrax 53 immunotherapeutic agent 53 stavudine lamivudine 53 p# MAP kinase inhibitor 53 HER1 53 TRX1 53 administered intramuscularly 53 CHEAP ONLINE PHARMACY BEST 53 quinolone antibiotic 53 selective kinase inhibitor 53 EZN 53 Miacalcin 53 gram negative aerobes 53 Allovectin 7 ® 53 APEX PD 53 vancomycin resistant 53 #mg q8h 53 tenofovir emtricitabine 53 PEG IFN 53 surgically resectable 53 Viprovex ® 53 LAB CGRP 53 Peg IFN 53 XL# XL# XL# 53 adefovir dipivoxil 53 pneumococcal serotypes 53 Lillian Jasewicz 53 Noxafil 53 Poly ICLC 53 Sphingomab TM 53 systemic antifungal 53 Adeno 53 resistant staphylococcus 53 novel synthetic peptide 53 Hydralazine 53 generation cephalosporin antibiotic 53 subcutaneous PRO 53 LT NS# 53 PROCTOCORT R 52 Velcade bortezomib 52 humanised antibody 52 BEXXAR Therapeutic Regimen 52 NMIBC 52 PEG interferon 52 Maleate 52 Crixivan 52 voriconazole 52 carbapenem 52 bevacizumab Avastin ® 52 SELZENTRY 52 doripenem 52 PEGylated interferon 52 Umbilical cord stem cells 52 REGENERON PHARMACEUTICALS 52 Vicinium TM 52 Secretase 52 nelfinavir Viracept 52 Moraxella catarrhalis 52 clinical trials Archexin ® 52 amoxicillin clavulanic acid 52 Nausea vomiting 52 chimeric monoclonal antibody 52 qualitative serum 52 trivalent influenza vaccine 52 HGS ETR2 52 rosiglitazone maleate 52 immunoconjugate 52 Candesartan 52 radiation sensitizer 52 Enzastaurin 52 Itraconazole 52 Liposomal 52 Budesonide 52 piroxicam 52 Oxytrex TM 52 dosing cohorts 52 Artemether 52 Blinatumomab 52 Haemophilus influenzae Moraxella catarrhalis 52 Pertuzumab 52 pharmacologically active isomer 52 Cotara ®